Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RD12014 vs Victoza in Type 2 Diabetes Mellitus
CTR20200400Phase 3Completed
- Sponsor
- HEC Pharm
- Start
- Mar 2020
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of liraglutide in type 2 diabetes mellitus (T2DM), sponsored by HEC Pharm. Started Mar 2020; status: completed.
02
Drugs
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20200400.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20200400.